These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12223441)

  • 1. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
    Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
    Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older.
    Giuliano AR; Papenfuss MR; Denman CA; de Zapien JG; Abrahamsen M; Hunter JB
    Int J STD AIDS; 2005 Mar; 16(3):247-51. PubMed ID: 15829027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection in men attending a sexually transmitted disease clinic.
    Baldwin SB; Wallace DR; Papenfuss MR; Abrahamsen M; Vaught LC; Kornegay JR; Hallum JA; Redmond SA; Giuliano AR
    J Infect Dis; 2003 Apr; 187(7):1064-70. PubMed ID: 12660920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grujnberga V; Grujnberg A; Juschenko A; Johansson B; Tosi P; Cintorino M; Santopietro R; Syrjänen K
    Sex Transm Dis; 2003 Sep; 30(9):680-4. PubMed ID: 12972789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
    Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
    J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
    Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
    J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of the spread of human papillomavirus infection.
    Silins I; Kallings I; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):953-9. PubMed ID: 11008914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus prevalence and type distribution in male anogenital sites and semen.
    Nielson CM; Flores R; Harris RB; Abrahamsen M; Papenfuss MR; Dunne EF; Markowitz LE; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1107-14. PubMed ID: 17548671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of human papillomavirus type 16 infection in the United States.
    Stone KM; Karem KL; Sternberg MR; McQuillan GM; Poon AD; Unger ER; Reeves WC
    J Infect Dis; 2002 Nov; 186(10):1396-402. PubMed ID: 12404154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.
    Nielsen A; Kjaer SK; Munk C; Iftner T
    Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
    J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of genital human papillomavirus detection in a US population.
    Peyton CL; Gravitt PE; Hunt WC; Hundley RS; Zhao M; Apple RJ; Wheeler CM
    J Infect Dis; 2001 Jun; 183(11):1554-64. PubMed ID: 11343204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students.
    Richardson H; Abrahamowicz M; Tellier PP; Kelsall G; du Berger R; Ferenczy A; Coutlée F; Franco EL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1149-56. PubMed ID: 15894665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women.
    Minkoff H; Shen X; Watts DH; Leighty R; Hershow R; Palefsky J; Tuomala R; Neu N; Zorrilla CD; Paul M; Strickler H
    Obstet Gynecol; 2006 Oct; 108(4):953-60. PubMed ID: 17012459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study.
    Roteli-Martins CM; de Carvalho NS; Naud P; Teixeira J; Borba P; Derchain S; Tyring S; Gall S; Diaz A; Blatter M; Shier RM; Romanowski B; Quint WG; Issam J; Galindo C; Schuind A; Dubin G
    Int J Gynecol Pathol; 2011 Mar; 30(2):173-84. PubMed ID: 21293281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.